Skip Navigation

Schizophrenia Bulletin 1998 24(3):479-488;
© 1998 by Oxford University Press and the Maryland Psychiatric Research Center (MPRC)
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Martin, B. C.
Right arrow Articles by Miller, L. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, B. C.
Right arrow Articles by Miller, L. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press

Expenditures for Treating Schizophrenia: A Population-Based Study of Georgia Medicaid Recipients

Bradley C. Martin and L. Stephen Miller
Assistant Professor of Clinical and Administrative Sciences, Department of Pharmacy Care Administration
Associate Professor of Clinical Psychology, Department of Psychology, University of Georgia Athens, GA

Reprint requests should be sent to Dr. L.S. Miller, Dept. Psychology, The University of Georgia, Athens, GA 30602-3013

The study analyzed all claims data for reimbursable medical services and drugs rendered to 18- to 50-year-old Medicaid recipients in the State of Georgia over a 3-year period. A cohort of 6,443 schizophrenia patients were identified by inspecting the medical history data for claims indicative of schizophrenia (ICD-9-CM 295.xx). A crude prevalence of 6.02 percent was identified. Use patterns and charges associated with schizophrenia were stratified by major areas of service including ambulatory services, hospitalizations, and pharmacological treatment. The incidence of rehospitalization for chronic schizophrenia patients based on a 12-month hospitalization index format was also identified. Findings are discussed regarding using these data to focus strategies for assessing schizophrenia treatment outcome in relation to treatment cost.

Keywords: Medicaid / economics / cost-of-illness


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Psychiatr. Serv.Home page
N. J. K. Breitborde, S. W. Woods, and V. H. Srihari
Multifamily Psychoeducation for First-Episode Psychosis: A Cost-Effectiveness Analysis
Psychiatr Serv, November 1, 2009; 60(11): 1477 - 1483.
[Abstract] [Full Text] [PDF]

Home page
 Clinical Case StudiesHome page
S. M. Silverstein
Integrating Jungian and Self-Psychological Perspectives Within Cognitive-Behavior Therapy for a Young Man With a Fixed Religious Delusion
Clinical Case Studies, June 1, 2007; 6(3): 263 - 276.
[Abstract] [PDF]

Home page
 Journal of the American Dental AssociationHome page
A. H. FRIEDLANDER and S. R. MARDER
The psychopathology, medical management and dental implications of schizophrenia
J Am Dent Assoc, May 1, 2002; 133(5): 603 - 610.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.